11-63952263-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2

The NM_024771.4(NAA40):​c.181C>G​(p.Arg61Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

NAA40
NM_024771.4 missense

Scores

3
9
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.33
Variant links:
Genes affected
NAA40 (HGNC:25845): (N-alpha-acetyltransferase 40, NatD catalytic subunit) Enables H2A histone acetyltransferase activity; H4 histone acetyltransferase activity; and peptide-serine-N-acetyltransferase activity. Involved in N-terminal protein amino acid acetylation; histone H2A acetylation; and histone H4 acetylation. Located in centriolar satellite; cytosol; and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NAA40NM_024771.4 linkc.181C>G p.Arg61Gly missense_variant Exon 4 of 8 ENST00000377793.9 NP_079047.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NAA40ENST00000377793.9 linkc.181C>G p.Arg61Gly missense_variant Exon 4 of 8 1 NM_024771.4 ENSP00000367024.4 Q86UY6-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Mar 29, 2022
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.181C>G (p.R61G) alteration is located in exon 4 (coding exon 4) of the NAA40 gene. This alteration results from a C to G substitution at nucleotide position 181, causing the arginine (R) at amino acid position 61 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.68
BayesDel_addAF
Pathogenic
0.38
D
BayesDel_noAF
Pathogenic
0.31
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.22
T;.
Eigen
Benign
0.19
Eigen_PC
Uncertain
0.26
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.90
D;D
M_CAP
Benign
0.011
T
MetaRNN
Uncertain
0.70
D;D
MetaSVM
Benign
-0.84
T
MutationAssessor
Uncertain
2.3
M;.
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-4.2
D;D
REVEL
Benign
0.24
Sift
Uncertain
0.0070
D;D
Sift4G
Benign
0.084
T;D
Polyphen
0.80
P;.
Vest4
0.88
MutPred
0.45
Gain of catalytic residue at R61 (P = 0.0424);.;
MVP
0.61
MPC
0.99
ClinPred
0.95
D
GERP RS
4.8
Varity_R
0.71
gMVP
0.89

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr11-63719735; COSMIC: COSV100624231; COSMIC: COSV100624231; API